Related Experiment Video
Updated: May 26, 2025

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
SARS-CoV-2-Specific Antibodies in Pediatric Solid Organ Transplant Recipients: Benefits of Additional Vaccine Doses
Amanda L Adler1, Alpana Waghmare1,2, Jodi Smith1,2
1Seattle Children's Research Institute, Seattle, Washington, USA.
Insights
Pediatric solid-organ transplant recipients show robust antibody responses after COVID-19 vaccination, with more doses leading to higher antibody levels. This study provides key longitudinal immune data for this high-risk group.
Area of Science:
- Immunology
- Transplantation
- Infectious Diseases
Background:
- Limited data exist on immune responses to COVID-19 infection and vaccination in pediatric solid-organ transplant (SOT) recipients.
- Pediatric SOT recipients represent a vulnerable population requiring specific immune monitoring.
Purpose of the Study:
- To investigate the development and durability of immune responses following COVID-19 infection and vaccination in pediatric SOT recipients.
- To assess antibody levels and neutralizing activity over time in this cohort.
Main Methods:
- Longitudinal study of 83 SOT recipients (<21 years) from August 2020 to May 2021.
- Collected blood samples for antinucleocapsid (N) and anti-spike (S) IgG antibody testing.
- Utilized vaccination data, Abbott Architect, Meso Scale Discovery (MSD), and pseudovirus-neutralization assays.
Main Results:
- 19.3% of participants showed evidence of SARS-CoV-2 infection.
- Antibody levels increased with the number of vaccine doses received.
- Neutralizing activity was reduced against Omicron subvariants compared to the ancestral strain.
Conclusions:
- Pediatric SOT recipients exhibit strong antibody responses post-COVID-19 vaccination.
- Higher antibody levels were observed after more than two vaccine doses.
- The study provides valuable longitudinal immune response data for this immunocompromised group.
Background:
Limited data are available regarding the development and durability of immune responses following COVID-19 infection or vaccination in pediatric solid-organ transplant (SOT) recipients.
Methods:
Renal, liver, or intestinal transplant recipients < 21 years of age followed at Seattle Children's Hospital were enrolled from August 2020 to May 2021. Blood samples were collected at ~6-month intervals for up to 3 years and tested for antinucleocapsid (N) antibodies. COVID-19 vaccination data were collected from the Washington State Immunization Information System and/or the medical record. Semi-quantitative anti-S IgG testing was performed on all postvaccine samples using the Abbott Architect platform. We further evaluated a subset of postvaccine samples using variant-specific quantitative binding (Meso Scale Discovery, MSD) immunoassays and pseudovirus-neutralization assays. Antibody levels were compared over time and by vaccine category.
Results:
We followed 83 SOT recipients for a median of 12.5 months (IQR 7.0, 28.3). Overall, 16 (19.3%) participants had evidence of SARS-CoV-2 infection based on anti-N antibody detection. Forty-six (55%) participants had a blood sample collected > 14 days after receipt of a vaccination. Serum IgG to spike antigens (anti-S antibody) increased following vaccination and increased with the number of vaccine doses received as assessed by both the Abbott and MSD assays. Neutralizing activity was significantly lower against the Omicron subvariants compared to the ancestral strain.
Conclusion:
Pediatric SOT recipients demonstrated strong antibody responses following SARS-CoV-2 vaccination, with higher anti-S antibody responses following > 2 doses of vaccine. Our study offers unique longitudinal immune response data in this vulnerable patient population.
More Related Videos
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Tumor Immunotherapy